aims of the study Hepatitis 8: Hepatitis C: Hepatitis 0: -evaluating the effect of acyclovir, zidovudine and Phyllanthus amarus on HBV replication in order to improve current treatment regimes concerning H Be-seroconversi on -defining quantitative HBeAg and HBV DNA analysis as parameters to monitor antiviral treatment - investigating the influence of indomethacin and paracetamol on the antiviral effect of a-IFN -evaluating the effect of rifampicin in addition to a-IFN treatment in a partial responder to a-IFN therapy - documenting that chronic hepatitis C complicated by coinfection with HIV can mimic autoimmune type chronic hepatitis and that antiviral therapy can lead to sustained remission of of hepatitis C. -evaluating the effect of treatment with a-IFN and ACV on chronic hepatitis D

, , ,
S.W. Schalm (Solko)
Erasmus University Rotterdam
De firma's Glaxo b.V., Essex Nederland B.V., Weilcome Pharmaceuticals B.V. en Abbott B.V. hebben een financiele bijdrage geieverd aan de kosten voor de promotie, waarvoor mijn hartelijke dank
hdl.handle.net/1765/40859
Erasmus MC: University Medical Center Rotterdam

Berk, L. (1991, November 6). Studies on treatment of chronic hepatitis B, C and D. Erasmus University Rotterdam. Retrieved from http://hdl.handle.net/1765/40859